PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
Gilching (pta019/15.02.2023/12:15) – Announcement
Gilching (pta019/15.02.2023/12:15) – Announcement
Gilching (pta010/17.01.2023/09:35) – Release of Voting Rights Announcement
Gilching (pta033/21.12.2022/16:40) – According to preliminary figures, Hönle Group was able to increase its sales in the 2021/2022 financial year by 9.9% to € 126.5 million compared to the previous year.
Gilching (pta026/15.12.2022/14:00) – Prof. Dr. Karl Hönle, company founder and long-time chairman of the supervisory board of Dr. Hönle AG will resign from office at the next Annual General Meeting on March 23, 2023 and will be leaving the Supervisory Board at his own request. The supervisory board of Dr. Hönle AG decided at its last meeting, to nominate Dr. Franz Richter as a new candidate for election to the Supervisory Board. It is intended that Dr. Richter will take over the chairmanship of the supervisory board then.
Gilching (pta024/12.12.2022/15:10) – As already announced on November 2, 2022, the Executive Board of Dr. Hönle AG decided to close the subsidiary Raesch Quarz (Germany) GmbH, Ilmenau, and to sell all the assets. Fortunately, an agreement has now been reached on the sale of the entire company to a new owner. Business operations therefore can be continued with the existing employees. The sale will take place retrospectively as of December 1, 2022. The purchase price is in the mid-single-digit million range.
Gilching (pta022/09.12.2022/15:24) – Release of Voting Rights Announcement
Gilching (pta026/02.12.2022/15:35) – The corona pandemic led to massive demand for mobile air purification devices that were used to reduce the germ load and control the risk of infection. The use of mobile air cleaning devices in public education and training facilities was also significantly encouraged by the grant of funding measures. In order to be able to participate in this market on a large scale, Dr. Hönle AG produced air sterilization devices in large numbers.
Gilching (pta016/02.11.2022/10:30) – The supervisory board of Dr. Hönle AG today approved the Management Board’s proposal to initiate restructuring measures at the subsidiary Raesch Quartz (Germany) GmbH, Ilmenau, while safeguarding the rights of the bodies responsible for operational co-determination. In order to implement this decision, the production and administration of Raesch Quarz (Germany) GmbH in Ilmenau are to be shut down. A total of around 70 jobs are expected to be lost as a result of these measures. The measures should be completed in the first half of the 2022/2023 financial year.
Gilching (pta021/19.10.2022/14:02) – Dr. Hönle AG announces that the following financial reports shall be disclosed:
Gilching (pta024/02.09.2022/12:00) – Release of Voting Rights Announcement